CLINICAL_TRIALS
trial_result
· 2024-07-17
Clinical Trial Update: Effect of Evolocumab on Coronary Atherosclerosis [Phase 3]
Summary
A Phase 3 clinical trial evaluating evolocumab for its effect on coronary atherosclerosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Cardiovascular Disease, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2024-07-17